Next-generation sequencing methods that provide multi-omic read-outs of CRISPR-modified cells reveal the relevance of genetic variants to disease states. Benjamin Izar is trying to work out what ...
In a recent Molecular Therapy: Nucleic Acids study, researchers demonstrate enhanced loss-of-function editing of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated ...
Morning Overview on MSN
A CRISPR treatment restored some sight to a woman born nearly blind
A woman born with almost no functional vision because of a genetic mutation has regained measurable sight after a single ...
Utah State University biochemists Thomson Hallmark and Ryan Jackson, along with collaborators, published two seminal papers this week. Their findings describe the structure and function of a newly ...
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...
For several years now, the CRISPR/Cas9 gene scissors have been causing a sensation in science and medicine. This new tool of molecular biology has its origins in an ancient bacterial immune system. It ...
Duchenne muscular dystrophy (DMD) is a muscle degeneration disorder caused by mutations affecting the dystrophin gene. Researchers show how a dual CRISPR RNA method restored dystrophin protein ...
SAN DIEGO--(BUSINESS WIRE)--Function Oncology, a company transforming the future of targeted cancer treatment with a CRISPR-powered precision medicine platform, today announced an upcoming ...
Genetics was supposed to revolutionize cancer care. The ability to sequence a tumor sample to identify cancer-driving mutations gave physicians a precision medicine approach to selecting the most ...
Precision medicine company Function Oncology has officially launched with the goal of revolutionizing the future of targeted cancer treatment by developing a CRISPR-powered, personalized functional ...
In a rare feat, Utah State University biochemists Thomson Hallmark and Ryan Jackson, along with collaborators, published not one, but two seminal papers in a top-tier, peer-reviewed journal this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results